These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 9644603

  • 1. [Clinical evaluation of combination therapy with cefpirome and amikacin for infections associated with hematological disorders].
    Fukuda M, Kobayashi Y, Endo K, Kawai N, Tominaga K, Bessho M, Hirashima K.
    Jpn J Antibiot; 1998 Apr; 51(4):298-304. PubMed ID: 9644603
    [Abstract] [Full Text] [Related]

  • 2. [Clinical effects of combination therapy with cefozopran and amikacin for infections in patients with hematological disorders].
    Fukuda M, Endo K, Takinami S, Kawai N, Tominaga K, Maesaki S, Bessho M, Yamazaki T.
    Jpn J Antibiot; 2001 Feb; 54(2):88-94. PubMed ID: 11338682
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Effect of combination therapy with sulbactam/cefoperazone and amikacin in the treatment of infectious diseases accompanied by hematological disorders].
    Matsushima T, Tamura K, Okamoto K, Kawada E, Murayama K, Maehara T, Sadakata H, Tamura J, Sawamura M, Morita K.
    Jpn J Antibiot; 1993 Aug; 46(8):697-705. PubMed ID: 8230737
    [Abstract] [Full Text] [Related]

  • 6. [A combined sulbactam/cefoperazone and amikacin therapy for the treatment of infections complicated with hematological diseases].
    Takashima T, Tsuda S, Misawa S, Horiike S, Kuzuyama Y, Hirakawa K, Nakai H, Seriu T, Tanaka S, Nishida K.
    Jpn J Antibiot; 1993 Mar; 46(3):251-8. PubMed ID: 8510322
    [Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of a combination treatment with cefbuperazone and amikacin in infections complicating with hematological disorders].
    Tanaka S, Tsuda S, Nakagawa H, Nishigaki H, Okuda T, Taniwaki M, Misawa S, Takino T, Abe T.
    Jpn J Antibiot; 1989 Dec; 42(12):2548-54. PubMed ID: 2614912
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.
    Pereira CA, Petrilli AS, Carlesse FA, Luisi FA, da Silva KV, de Martino Lee ML.
    J Microbiol Immunol Infect; 2009 Apr; 42(2):141-7. PubMed ID: 19597646
    [Abstract] [Full Text] [Related]

  • 10. [Clinical evaluation of cefbuperazone in severe infections complicated with hematological disorders].
    Mizuno H, Yamao H, Saito H, Ohno R, Hotta T, Ohnishi K, Murate T, Kagami Y, Mitomo Y, Nitta M.
    Jpn J Antibiot; 1990 Dec; 43(12):2078-86. PubMed ID: 2086822
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Clinical effects of a combination treatment with cefodizime and minocycline for infections in patients complicated with hematological disorders].
    Hirakawa K, Tsuda S, Misawa S, Kuzuyama Y, Nakai H, Seriu T, Takashima T, Tanaka S, Nishigaki H, Yokota S.
    Jpn J Antibiot; 1993 Aug; 46(8):686-96. PubMed ID: 8230736
    [Abstract] [Full Text] [Related]

  • 13. [Cefepime/amikacin in the empirical antibacterial therapy for patients with hemoblastosis of different forms].
    Chudanova TV, Abdulkadyrov KM, Chebotkevich VN.
    Antibiot Khimioter; 2003 Aug; 48(7):29-32. PubMed ID: 14628576
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Therapeutic effects of a combination treatment with flomoxef and tobramycin against infections complicated with hematological disorders].
    Yamane T, Tanaka K, Hasuike T, Hirai M, Misu K, Ota K, Ohira H, Nakao Y, Yasui Y, Inoue T.
    Jpn J Antibiot; 1992 Aug; 45(8):1050-9. PubMed ID: 1433894
    [Abstract] [Full Text] [Related]

  • 16. [Clinical evaluation of cefozopran for infections associated with hematological malignancies].
    Sasai Y, Iwai T, Tamura A, Nakazawa N, Ueda Y, Kaneko H, Horiike S, Yokota S, Taniwaki M, Kashima K, Misawa S, Tsuda S, Ohgawara Y.
    Jpn J Antibiot; 1998 Aug; 51(8):501-8. PubMed ID: 9836122
    [Abstract] [Full Text] [Related]

  • 17. [Clinical evaluation of combination therapy with sulbactam/cefoperazone and amikacin sulfate for infections associated with hematological disorders].
    Fukuda M, Hirashima K.
    Jpn J Antibiot; 1993 Oct; 46(10):912-7. PubMed ID: 8254893
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical evaluation of amikacin in severe infections with hematological malignant diseases (author's transl)].
    Hotta T, Hirabayashi N, Shimizu K, Utsumi M, Katoh T, Maeda H, Hirano A, Ohnishi K, Murate T, Yamada H.
    Jpn J Antibiot; 1981 Nov; 34(11):1457-64. PubMed ID: 7334580
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.